Русский
Realities of complex therapy of lipitension in comorbid patients at the outpatient stage
DOI: https://dx.doi.org/10.18565/pharmateca.2024.6.72-78
Gorban V.V., Gerasimenko I.A., Kovrigina I.V., Kameneva E.S., Gorban E.V.
1) Kuban State Medical University, Krasnodar, Russia; 2) “Preobrazhenskaya Clinic” LLC, Krasnodar, Russia; 3) Outpatient Department for the Contractual Population of Krasnodar, Research Institute - Regional Clinical Hospital No. 1, Krasnodar, Russia; 4) Policlinic for Specialized Course Outpatient Treatment, Clinical Hospital No. 2, Krasnodar, Russia
Background. The global spread of lipitension (syntropy of arterial hypertension – AH and dyslipidemia) with damage to target organs and the development of polymorbid pathology dictates the need for its early diagnosis and treatment at the stage of primary health
care.
Objective. Evaluation of the effectiveness of combination therapy with antihypertensive drugs (AHDs) and statins in patients with lipitension and comorbid pathology, taking into account the rational use of multipurpose polypills at the outpatient stage.
Methods. Outpatient cards of 240 patients with insufficiently effective antihypertensive therapy were studied in the Kuban State Medical University. An analysis of data physical examination, anthropometry data, blood lipidogram, electrocardiography, therapy with AHDs and statins was carried out.
Results. The prevalence of separate prescription of antihypertensive drugs and lipid-lowering drugs with insufficient AH control (up to 66%) and low-density lipoproteins – LDL (up to 30%) should be accompanied not only by intensification of separate combination therapy, but also by the use of a strategy for treating outpatients with multi-target fixed triple combinations in polypills.
Conclusion. The control of hypertension in 82.1% and LDL-C in 57.1% of patients with lipitension achieved with the use of Equamer when using maximum doses of the components in the polypill (amlodipine, lisinopril, rosuvastatin) may be even more significant.
care.
Objective. Evaluation of the effectiveness of combination therapy with antihypertensive drugs (AHDs) and statins in patients with lipitension and comorbid pathology, taking into account the rational use of multipurpose polypills at the outpatient stage.
Methods. Outpatient cards of 240 patients with insufficiently effective antihypertensive therapy were studied in the Kuban State Medical University. An analysis of data physical examination, anthropometry data, blood lipidogram, electrocardiography, therapy with AHDs and statins was carried out.
Results. The prevalence of separate prescription of antihypertensive drugs and lipid-lowering drugs with insufficient AH control (up to 66%) and low-density lipoproteins – LDL (up to 30%) should be accompanied not only by intensification of separate combination therapy, but also by the use of a strategy for treating outpatients with multi-target fixed triple combinations in polypills.
Conclusion. The control of hypertension in 82.1% and LDL-C in 57.1% of patients with lipitension achieved with the use of Equamer when using maximum doses of the components in the polypill (amlodipine, lisinopril, rosuvastatin) may be even more significant.
Keywords: lipotension, polypills, antihypertensive drugs, arterial hypertension, dyslipidemia, statins
About the Autors
Corresponding author: Vitaly V. Gorban, Dr. Sci. (Med.), Head of the Department of Outpatient Therapy with a Course in GMP (Family Medicine), Kuban State Medical University, Krasnodar, Russia; gorbanvv@mail.ru
Similar Articles
